Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company that specializes in developing innovative therapies for psychiatric and neurological disorders. With a focus on precision medicine, Minerva aims to improve the lives of patients suffering from conditions such as major depressive disorder, schizophrenia, and insomnia. Through rigorous scientific research and strategic partnerships, the company strives to pioneer groundbreaking treatments and reshape the future of mental healthcare.
